The developmental and inflammatory disease target protein ADAM17 is vulnerable to off-target interaction by the drug eltrombopag: Insights from molecular modeling. - Shahid Puthiyottil; Deepthi Jose; Nishamol Kuriakose; Tom Skaria (Comput. Biol. Medicine, 2025)